A 50,000+ study out of the University of Oxford shows while “breakthrough” infections with Delta have similar viral loads (Ct) to unvaccinated individuals, vaccination DOES REDUCE transmission of Delta and vaccinated individuals are LESS LIKELY to spread the Coronavirus. 🧵
Pre-Delta, vaccination reduced transmission of SARS-CoV-2 from individuals infected despite vaccination, potentially via reducing viral loads. While vaccination still lowers the risk of infection, similar viral loads in vaccinated and unvaccinated individuals infected with Delta
question how much vaccination prevents onward transmission. Researchers here performed a retrospective observational cohort study of contacts of SARS-CoV-2-infected index cases using contact testing data from England. They used multivariable logistic regression to investigate the
impact of index case and contact vaccination on transmission, and how this varied with Alpha (B.1.1.7) and Delta (B.1.617.2) variants (classified using S-gene detection/calendar trends) and time since second vaccination. So what did they find? A couple of really important things.
51,798/139,164 contacts tested were PCR-positive. Two doses of Pfizer’s or AstraZeneca’s vaccines in Alpha variant index cases independently reduced PCR-positivity in contacts. The Delta variant attenuated vaccine-associated reductions in transmission: two doses of Pfizer reduced
Delta transmission slightly more than AstraZeneca’s. Variation in viral load (Ct values) explained ONLY a modest proportion of vaccine-associated transmission reductions. THIS is important. Why? BECAUSE CT VALUES ARE NOT A MEASURE OF INFECTIOUSNESS.
The authors state: “Factors OTHER than PCR-measured viral load are important in vaccine-associated transmission reductions.'' Let’s continue. Transmission reductions did slightly decline over time HOWEVER the effects on reducing susceptibility to infection appeared stronger and
remained well preserved, despite some waning. WITH THIS SAID, there was an age dependent effect. Researchers state some of the observed decline may be attributable to the fact that those clinically vulnerable with weaker immune systems were vaccinated longer ago, which is why
boosters are beneficial for those who are most high-risk as they will help control transmission AND help prevent infections. Researchers also found there were much lower rates of secondary infection from child index cases AND lower secondary infection in child contacts.
So what does this tell us? Firstly, this is ONLY pertaining to breakthrough infections in vaccinated individuals. Why is this important? Because this only applies to WHEN and IF they happen! Preventing infection IS preventing transmission as well. The vaccines do a very good job
of preventing you from facing symptomatic infection in the first place! Listen to me clearly here so that you can pass it on as well: vaccinated individuals are not more likely to transmit to others. We know they can transmit however, they are indeed LESS likely to get infected
in the first place and therefore also LESS likely to transmit to others. This study shows us that while viral load may be the same, vaccinated individuals who DO get infected are LESS likely to be infectious than unvaccinated individuals with a naive infection.
Their conclusion? Vaccination reduces transmission of Delta, but by less than the Alpha variant. Vaccination also reduces virus shedding time, prevents symptomatic infection, & the presence of an immune response elicited by the vaccines will ultimately suppress the viable virus.
You can find this study here: medrxiv.org/content/10.110… I also HIGHLY recommend this fantastic article: No, Vaccinated People Are Not ‘Just as Likely’ to Spread the Coronavirus as Unvaccinated People: theatlantic.com/ideas/archive/… as well as my previous threads of studies on this topic.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
So, not COVID-19 related, however, this is really exciting news I wanted to share. Phase I trials of Moderna's HIV vaccine candidate, mRNA-1644, which uses the same mRNA technology as our COVID-19 vaccine, is expected to begin clinical trials this month!
Approximately 38 million people worldwide are currently living with HIV with 1.2 million in the U.S. Approximately 2 million new infections of HIV are acquired worldwide every year and approximately 690,000 people die annually due to complications from HIV/AIDS.
mRNA-1644 is a novel approach to HIV vaccine strategy in humans designed to elicit broadly neutralizing HIV-1 antibodies (bNAbs). The Phase 1 study for mRNA-1644 will use iterative testing to validate the approach and antigens and multiple novel antigens will be used
Portugal, a country who once had the world’s highest number of COVID-19 cases proportionate to its population, now has the world’s HIGHEST vaccination rate. 84% of Portugal’s population is now fully vaccinated. The country will lift most pandemic restrictions on October 1st.
Note: That is 8.5 million people fully vaccinated, and this has been in a matter of months. The nation went from vaccinating only 7000 citizens a day in January, to three months later 44,000 daily doses in April, and 150,000 doses PER DAY at its vaccination peak on July 12th.
In just a few days, nightclubs and bars will be allowed to reopen to those with a digital vaccination certificate or negative COVID-19 test, after having been shut since March 2020. Digital certificates or negative tests will no longer be mandatory in hotels and gyms, but will
This is fantastic. 99.4% of Undergraduates, 97.8% of Graduates, 95.1% of Faculty, and 92.5% of Staff at Yale University are now fully vaccinated. ZERO cases among Undergraduates. Only three positive cases within the last seven days. This week, Yale has a 0.02% positivity rate.
Classes began on September 1st for Undergraduates. Aspects of life at Yale are beginning to resemble something more like their pre-pandemic form amid high rates of vaccination within the university population and the continuation of some key public health protocols.
A study out of Harvard shows while breakthrough infections with Delta have similar peak viral loads (Ct) to that of unvaccinated individuals, viral loads decrease faster in vaccinated individuals AND they are contagious for a SHORTER period of time, and harbor less virus overall.
Researchers quantified the course of viral proliferation and clearance for 173 individuals with acute SARS-CoV-2 infections using longitudinal quantitative RT-PCR tests conducted using anterior nares/oropharyngeal samples (n = 199,941) as part of the National Basketball
Association’s (NBA) occupational health program between November 28th, 2020, and August 11th, 2021. Researchers then measured the duration of viral proliferation and clearance and the peak viral concentration separately for individuals infected with Alpha (B.1.1.7), Delta
An analysis of an outbreak of the Delta variant in Ontario, Canada during an indoor event shows there was no further transmission to fully vaccinated household members AND there was NO further transmission from breakthrough cases. Vaccination stopped the train of transmission.🧵
Some considerations to keep in mind. This group IS NOT eligible for COVID-19 vaccination and the outbreak occurred during an indoor high-intensity sports event. There were two distinct COVID-19 exposures on different teams with players under the age of 12. The teams did not play
against each other. Overall, 1 in 3 players on each team were infected (see infographic for more details). There was no further transmission to players on other exposed teams, OR to fully vaccinated household members. Transmission did occur from player cases to 2 of 22 household
Impressive data out of Malaysia. 14.5M participants. RECoVAM study shows full vaccination reduces the risk of infection by 88% and symptomatic disease by 86%.
Overall, the COVID-19 Vaccines cut ICU Admission risk by 83% and Deaths due to COVID-19 by 88% according to the study.
ICR Director Dr. Kalaiarasu said findings by the Real-World Evaluation of Covid-19 Vaccines Under the Malaysia National Covid-19 Immunization Program (RECoVaM) showed that the overall ICU rate amongst fully vaccinated individuals-14 days after the second vaccine dose in a